Biosyent Inc V.RX

Significant Outside Position Announced

[overnout]

TORONTO, June 11, 2021 (GLOBE NEWSWIRE) --  FAX Capital Corp. (FAX or the Company) (TSX: FXC & FXC.WT) is pleased to announce that it has acquired ownership of 902,000 common shares (the Shares) of  BioSyent Inc. (BioSyent) (TSXV: RX) through the facilities of the Neo Exchange Inc. (the Acquisition). The Shares were acquired at an average price of $7.50 per Share and an aggregate purchase price of $6,765,000. Immediately prior to the Acquisition, the Company owned 1,219,100 Shares, representing 9.59% of the outstanding Shares. Following the completion of the Acquisition, FAX now owns 2,121,100 Shares, representing 16.69% of the total number of outstanding Shares of BioSyent.

The Company currently has no plans or intentions with respect to the acquired Shares of BioSyent and the Shares are being held for investment purposes. In the future, the Company may acquire additional Shares, or dispose of its holdings, both as investment conditions warrant.

[Possibleidiot01]

You might want to look at the track record of Fax Capital, Good stockpickers imho . They made a lot of money on People Corporation who were bought by Goldman Sachs . Current holdings below - some of which are well up like Hamilton Thorne and Information Services Corporation 12.6% Share of portfolio fair value As at 2021-03-31 11.9% Share of

[theinvestor22]

It seems this NR has been the catalyst for a price increase.  Not much volume, other than the cross trade referenced in this NR, but the increase is still welcome.  Still way undervalued here, but it doesn't really matter.  This is a great long term keeper.